Armata Pharmaceuticals

$ARMP is currently up over 15% and leading the Prism MarketView Pharmaceuticals Index. $ARMP has risen over the last month due to positive updates on its AP-PA02 and AP-SA02 studies

Share This Article

 

About the Author

Armata Pharmaceuticals

Joey Ramson